Youcare Pharmaceutical Group Co (SHSE:688658) Research & Development: ¥448 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688658 Youcare Pharmaceutical Group Co Ltd SHSE:688658
56 GF Score
Price ¥13.40
GF Value ¥12.28
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Youcare Pharmaceutical Group Co Research & Development?

Youcare Pharmaceutical Group Co SHSE:688658 -6.10% 56 Research & Development is ¥448 Mil as of Jun. 2026. GuruFocus rates SHSE:688658 with a GF Score™ of 56/100 and a GF Value™ of ¥12.28 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Youcare Pharmaceutical Group Co's Research & Development for the three months ended in Jun. 2026 was ¥118 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was ¥448 Mil.

Youcare Pharmaceutical Group Co  (SHSE:688658) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Youcare Pharmaceutical Group Co Research & Development Related Terms

Youcare Pharmaceutical Group Co Research & Development Historical Data

* Premium members only.

The historical data trend for Youcare Pharmaceutical Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Youcare Pharmaceutical Group Co Research & Development Chart

Youcare Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 200.03 344.42 351.88 374.31 441.21

Youcare Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.88 113.50 124.65 91.69 118.36
SHSE:688658
56GF Score
Youcare Pharmaceutical Group Co Ltd SHSE:688658
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Youcare Pharmaceutical Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥448 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥448 Mil mean?
Youcare Pharmaceutical Group Co (SHSE:688658) has a Research & Development of ¥448 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Youcare Pharmaceutical Group Co and its competitors.
Is Youcare Pharmaceutical Group Co's Research & Development too high?
Youcare Pharmaceutical Group Co's current Research & Development is ¥448 Mil. Overall, Youcare Pharmaceutical Group Co has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Youcare Pharmaceutical Group Co's Research & Development compare to VRTX and REGN?
Youcare Pharmaceutical Group Co's Research & Development of ¥448 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Youcare Pharmaceutical Group Co and its competitors. Youcare Pharmaceutical Group Co's current Research & Development is ¥448 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Youcare Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co (SHSE:688658) is currently considered Fairly Valued. The stock's GF Value™ is ¥12.28, compared to a current price of ¥13.40 — trading 9.1% above its estimated fair value. The current Research & Development is ¥448 Mil. Youcare Pharmaceutical Group Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Youcare Pharmaceutical Group Co (SHSE:688658), the current Research & Development is ¥448 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Youcare Pharmaceutical Group Co (SHSE:688658) Overvalued in 2026?

Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥13.40 is trading 9.1% above its estimated GF Value™ of ¥12.28. GuruFocus considers Youcare Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for SHSE:688658:

  • Research & Development: ¥448 Mil
  • GF Value™: ¥12.28 vs. price of ¥13.40 (9.1% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Youcare Pharmaceutical Group Co Business Description

Address No. 6, Hongda Middle Road, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
56GF Score

Get the complete analysis for SHSE:688658

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.40
Price
¥12.28
GF Value